Status:
UNKNOWN
Efficacy of Repeated Low-Level Red-Light Therapy in Myopia Control
Lead Sponsor:
Zhongshan Ophthalmic Center, Sun Yat-sen University
Collaborating Sponsors:
Shenzhen Children's Hospital
The Second People's Hospital of Foshan
Conditions:
Myopia
Refractive Errors
Eligibility:
All Genders
8-13 years
Phase:
NA
Brief Summary
The purpose of this study is to determine if repeated low-level red-light therapy can slow myopia progression in Chinese schoolchildren.
Detailed Description
Low level light therapy (LLLT) is an innovative and non-invasive therapeutic treatment for a variety of eye diseases. Its potential mechanisms of improving choroidal metabolic rate and circulation may...
Eligibility Criteria
Inclusion
- Age at enrolment: 8-13 years
- Spherical equivalent refractions (SERs): -1.00 to -5.00 diopters (D)
- Astigmatism of 2.50 D or less
- Anisometropia of 1.5 D or less
- Spectacle corrected monocular logMAR visual acuity (VA): 0 or better
- Parents' understanding and acceptance of random allocation of grouping
Exclusion
- Strabismus and binocular vision abnormalities in either eye
- Ocular abnormalities in either eye or other systemic abnormalities
- Prior treatment of myopia control, e.g. drugs, orthokeratology, progressive addition lenses, bifocal lenses, etc in either eye
- Other contraindications in either eye
Key Trial Info
Start Date :
July 23 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
264 Patients enrolled
Trial Details
Trial ID
NCT04073238
Start Date
July 23 2019
End Date
December 1 2022
Last Update
January 6 2022
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
The Second People's Hospital of Foshan
Foshan, Guangdong, China, 528000
2
Zhongshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, China, 510060
3
Shenzhen Children's Hospital
Shenzhen, Guangdong, China, 518038
4
Xiangya Hospital, Central South University
Changsha, Hunan, China, 410008